Jillian Petrera and I are pleased to be joining the Association of National Advertisers next week to discuss Cannabis and CBD marketing and advertising pitfalls. We will also provide legislative, litigation, and government enforcement updates, including a discussion of the impact that COVID-19 has had on the industry. The FDA and FTC have been busy issuing Warning Letters to companies claiming that their products treat COVID-19 - tune in for key takeaways and lessons learned from these enforcement actions.
Register here to join us: https://www.ana.net/webinars/show/id/LRE-200512
Potential Pitfalls in Cannabis & CBD Marketing Many marketers are rightfully confused by the maze of federal and state regulations around cannabis and CBD (cannabidiol, a component of the cannabis plant typically sold as CBD oil – and also increasingly infused in various products advertised to consumers). Cori Goldberg and Jillian Petrera of Reed Smith LLP will provide a regulatory, enforcement and litigation update on where things stand in this rapidly developing industry. The presentation will include a discussion of recent Food and Drug Administration (FDA) and Federal Trade Commission (FTC) enforcement actions, state and federal litigation, as well as recent legislative updates.